The staged process by which a new medicine is tested in humans before it can be considered for regulatory approval. Phase 1 trials test safety and dosing in a small number of healthy volunteers. Phase 2 trials test whether a treatment shows a genuine effect in a larger group of people with the relevant condition. Phase 3 trials test it in a much larger, more diverse population to confirm effectiveness and monitor side effects, and usually form the main evidence base for a regulatory decision. Reaching a later phase means a treatment has cleared more evidentiary hurdles, but it does not by itself mean the treatment has been shown to be safe or effective.
Peptides where this matters
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.